M. Niemeyer

Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26‐week randomized, open‐label, treat‐to‐target non‐inferiority trial

Melanie J. Davies, J. L. Gross, Yuichiro Ono et al. · Diabetes Obesity and Metabolism · 2014 · 53 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +16

Insulin degludec improves long‐term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal‐bolus insulin therapy

Priscilla Hollander, Allen B. King, Stefano Del Prato et al. · Diabetes Obesity and Metabolism · 2014 · 34 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +15

Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals

Timothy S. Bailey, Jerome E. Thurman, M. Niemeyer et al. · Current Medical Research and Opinion · 2011 · 32 citations

Pharmacy, Clinical Pharmacy, Comparative Effectiveness Research +13

Self-assessment and objective determination of dexterity in patients with type 1 or type 2 diabetes mellitus

A Pfützner, Petra B. Musholt, Christina Schipper et al. · Current Medical Research and Opinion · 2011 · 15 citations

Medicine, Internal Medicine, Diabetology +16